Infectious Disease
U.S. COVID-19 Infections, Deaths Drop to Levels Not Seen Since Last Summer
United States reporting about 25,700 new COVID-19 cases daily, a 39 percent decrease from two weeks ago
Approved Vaccines ‘Respond’ to All COVID-19 Variants So Far: WHO
However, unknown variants of the virus could still emerge and be resistant to existing vaccines
Physician’s Briefing Weekly Coronavirus Roundup
Backyard Poultry Tied to Salmonella Outbreak in Dozens of States: CDC
34 people had been hospitalized, but no deaths had been reported
Meds Used for Hospitalized COVID-19 Patients Shifted Over 2020
Dexamethasone and remdesivir use grew substantially, while azithromycin and hydroxychloroquine both declined from early peaks
Risk for Post-COVID-19 Clinical Sequelae Examined in Adults
Risk increased for new sequelae attributed to SARS-CoV-2 infection, including chronic respiratory failure, myocarditis, anxiety, fatigue
FDA Eases Storage Rules for Pfizer COVID-19 Vaccine
New guidance means the vaccine can be used in more locations that do not have ultra-cold storage facilities
COVID-19 Booster Shots Likely Needed Within a Year: Fauci
Fauci also said that variant-specific booster shots may not be needed
SARS-CoV-2 Seropositivity Not Associated With Low Vitamin D
SARS-CoV-2 seropositivity not linked to having vitamin D level less than 20 ng/mL or less than 30 ng/mL before or during pandemic
Presentation of Multisystem Inflammatory Syndrome Varies in Adults
60 percent of patients with MIS-A had acute COVID-19 symptoms, 20 percent were admitted for COVID-19 before being admitted for MIS-A
